Aspirin; propoxyphene napsylate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for aspirin; propoxyphene napsylate and what is the scope of patent protection?
Aspirin; propoxyphene napsylate
is the generic ingredient in one branded drug marketed by Aaipharma Llc and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for aspirin; propoxyphene napsylate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
DailyMed Link: | aspirin; propoxyphene napsylate at DailyMed |
US Patents and Regulatory Information for aspirin; propoxyphene napsylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aaipharma Llc | DARVON-N W/ ASA | aspirin; propoxyphene napsylate | CAPSULE;ORAL | 016829-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aaipharma Llc | DARVON-N W/ ASA | aspirin; propoxyphene napsylate | TABLET;ORAL | 016863-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |